Saturday 17 October 2026 Export RPRX’s income statement to Excel — free account

Royalty Pharma PLC

Royalty Pharma PLC’s revenue for fiscal 2025 (year ended December 2025) was $2.4 billion, up 5.06% from fiscal 2024. In the quarter to June 2026, revenue grew 16.5%, EPS fell 40.0%, free cash flow grew 31.6% and total debt rose 12.0%, each against the same quarter a year earlier. Dividend growth for five consecutive years.

61.29 1.67 +2.80%

Follow RPRX

Alert me

Market cap: $34.3B
P/E: 42.3×
Fwd P/E: 21.9×
Dividend yield: 1.51%
F-score: 5/9
Altman Z: 1.61
Beneish M: −2.83
Dividend safety: 37/100

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Jun '26	Mar '26	Dec '25	Sep '25	Older periods
P/E ratio Full definition →	38.67	32.63	28.62	26.73	+8 more quarters Free account
P/S ratio Full definition →	9.84	8.59	6.98	6.48
P/FCF ratio Full definition →	19.05	17.53	4.72	4.44
P/Operating CF Full definition →	34.26	29.17	20.08	21.69
P/B ratio Full definition →	2.55	2.11	1.71	1.58
Price to Tangible BV Full definition →	2.82	2.32	1.89	1.75
EV/Sales Full definition →	13.04	12.01	10.48	9.88
EV/EBITDA Full definition →	21.38	18.04	15.65	14.87
EV/Operating CF Full definition →	11.11	11.22	10.01	9.66
EV/FCF Full definition →	25.25	24.51	7.09	6.77
Quick Ratio Full definition →	1.38	1.19	1.05	1.85
Current Ratio Full definition →	2.80	2.66	2.40	3.48
Net Debt/EBITDA Full definition →	57.16	14.60	20.93	18.32
Debt/Assets Full definition →	45.22%	45.20%	45.62%	46.24%
Debt/Equity Full definition →	0.92	0.90	0.92	0.93
Asset Turnover Full definition →	0.13	0.13	0.13	0.13
Operating CF/Net income Full definition →	40.73	2.44	3.92	2.44
Capex/Depreciation Full definition →	(27.81)	(51.17)	0.00	(105.46)
Interest Coverage Full definition →	1.42	6.01	4.12	5.37
Research and Development Expense of Revenue Full definition →	14.51%	6.31%	8.12%	8.29%
Selling, General and Administrative Expense of Revenue Full definition →	24.01%	25.29%	26.41%	19.49%
Intangible Assets out of Total Assets Full definition →	0.05	0.05	0.05	0.05
Share Based Compensation of Revenue Full definition →	15.88%	19.35%	20.22%	11.96%
Graham Net Nets Full definition →	(0.33)	(0.40)	(0.50)	(0.52)
Graham Number Full definition →	26.78	27.43	26.20	25.72
Earnings Yield Full definition →	2.59%	3.06%	3.49%	3.74%
Free Cash Flow Yield Full definition →	5.25%	5.71%	21.18%	22.53%
Revenue per Share Full definition →	1.51	1.44	1.45	1.41
Operating CF per Share Full definition →	1.64	1.64	1.92	1.63
Capex per Share Full definition →	(0.56)	(1.04)	0.00	(2.23)
Free Cash Flow per Share Full definition →	1.07	0.61	1.92	(0.60)
Cash per Share Full definition →	1.88	1.39	1.48	2.21
Shareholders Equity per Share Full definition →	21.99	22.75	22.60	22.28
Interest Debt per Share Full definition →	0.00	0.00	0.00	0.00
Book value per Share Full definition →	21.99	22.75	22.60	22.28
Free Cash Flow Full definition →	477.44	265.87	827.15	(259.26)
Working Capital Full definition →	1,133.64	890.13	891.88	1,318.74
Capital Expenditures Full definition →	(251.02)	(452.37)	—	(961.87)
Net Current Asset Value Full definition →	(8,269.49)	(8,452.77)	(8,377.75)	(7,876.88)
EV/EBIT Full definition →	21.88	18.45	15.98	15.16
Capex to Sales Full definition →	0.37	0.72	0.00	1.58
Price to Operating Income Full definition →	16.51	13.19	10.65	9.94
Other line items
Average Receivables Full definition →	29.61	25.65	28.14	26.90
Average Payables Full definition →	27.89	31.56	16.39	31.74
Average Assets Full definition →	19,071.39	18,711.84	18,921.75	18,694.76
Average Common Equity Full definition →	9,644.33	9,862.75	10,028.65	9,939.67

Show all line items

Columns are period end dates

Stockrow Weekly